Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0TT5K
|
|||
Former ID |
DIB016726
|
|||
Drug Name |
MDL-27531
|
|||
Synonyms |
4-Methyl-5-(methylsulfonyl)-3-phenyl-1,2,4-triazole
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Epilepsy [ICD-11: 8A60-8A68] | Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H11N3O2S
|
|||
Canonical SMILES |
CN1C(=NN=C1S(=O)(=O)C)C2=CC=CC=C2
|
|||
InChI |
1S/C10H11N3O2S/c1-13-9(8-6-4-3-5-7-8)11-12-10(13)16(2,14)15/h3-7H,1-2H3
|
|||
InChIKey |
DPGDRICHXKQXEN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 116850-44-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glycine receptor (GlyR) | Target Info | Modulator | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Ligand-gated ion channel transport | |||
WikiPathways | Iron uptake and transport |
References | Top | |||
---|---|---|---|---|
REF 1 | MDL 27,531 reduces spontaneous hindlimb contractions in rats with chronic transections of the spinal cord. Neurosci Lett. 1992 Nov 23;147(1):101-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.